Pharmaceutical Pricing and Healthcare Access

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-03-02-2004, Volume 28, Issue 3

Healthcare coverage and costs remain prime concerns for FDA as the number of uninsured Americans continues to grow.

Related Content:

Regulatory WatchPharmaceutical Technology-03-02-2004
FDA and Industry Prepare for End to COVID-19 Emergency
Kudos and Hurdles in Tackling Rare Diseases
Vaccine Development Builds on COVID-19 Breakthroughs